InvestorsHub Logo
Followers 14
Posts 898
Boards Moderated 0
Alias Born 03/07/2011

Re: None

Wednesday, 01/07/2015 8:31:48 AM

Wednesday, January 07, 2015 8:31:48 AM

Post# of 2958
ENTA to present preclinical NASH data at JPM conference on 1/14

http://uk.advfn.com/news/BW/2015/article/65014300?xref=newsalerttweet&adw=1126416

Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will present a corporate overview that will include an update on Enanta’s development pipeline, including preclinical data from Enanta’s new research program in non-alcoholic steatohepatitis (NASH), on January 14, 2015 at 11:00 a.m. PT during the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News